Categories: News

PetMed Express d/b/a 1-800-PetMeds to Announce Its First Quarter Financial Results on July 26, 2021

DELRAY BEACH, Fla., July 19, 2021 (GLOBE NEWSWIRE) — PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended June 30, 2021 on Monday, July 26, 2021 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, the Company will host a conference call to review the financial results.

To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025, ten minutes prior to the scheduled start time. Callers will be required to supply PETMEDS as the passcode, and will be placed on hold with music until the call begins.

For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. Eastern Time on July 26, 2021 until August 9, 2021 at 11:59 P.M. Eastern Time. To access the replay, call (866) 360-7718 (toll free) or (203) 369-0170, and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2021. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company’s Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.

Contact:    Bruce S. Rosenbloom, CFO
Phone:     (561) 526-4444 
Fax:    (561) 526-4434

       
                     
               

Staff

Recent Posts

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval

FSA Publishes Safety Assessment for cbdMD's Proprietary CBD IngredientCharlotte, North Carolina--(Newsfile Corp. - April 7,…

2 hours ago

Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP)…

2 hours ago

FendX Provides Shareholder Update

Oakville, Ontario--(Newsfile Corp. - April 7, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

3 hours ago

Lenire Supports Veterans by Sponsoring Hearoes Tour

Lenire proudly sponsors the 10th Annual LexCare Hearing Foundation Hearoes Tour.Lenire is a treatment option…

3 hours ago

Millions of people unite around doing good on the 19th International Good Deeds Day held yesterday worldwide

Good Deeds Day continues to expand worldwide, as the peak event of year-round volunteer activities.…

3 hours ago

Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with Its CT 3500 Imaging Solution

Philips CT 3500, a scalable, adaptable, and durable imaging solution, improves efficiency and care quality,…

9 hours ago